Roswell Park Cancer Institute is celebrating its ranking among the top 6 percent of hospitals for blood and bone marrow transplants, based on patient survival rates.
The ranking by the Center for International Blood and Marrow Transplant Research (CIBMTR) places Roswell Park among the top sites in the nation for the third consecutive year.
The national group looked at outcomes for patients receiving blood and marrow transplants.
Procedures examined include allogeneic blood and marrow transplantation, which involve infusion of bone marrow or blood cells from a donor. According to Roswell Park, the procedure is commonly used to treat many blood cancers, including some forms of leukemia, multiple myeloma and lymphoma.
An international research organization that collects and publishes data, the CIBMTR included 169 centers in the 2012 report on outcomes data for transplants performed between 2008 and 2010. Roswell Park was placed among the 10 centers whose one-year survival results were above what could be expected based on the level of risk.
Roswell Park's population of patients were assigned to the highest risk category, indicating that its transplant cases during the period covered were among the most complicated.
The hospital, based on the Buffalo Niagara Medical Campus, is currently working on a $1.7 million expansion of its blood and marrow transplant clinic. The project, set to be completed next year, calls for shifting the clinic to a larger space within the hospital and more than doubling exam rooms from four to 10.